HALO
HALOZYME (HALO) Plans $1.05 Billion Convertible Note Offering Due 2033
Halozyme will sell $1.05 billion of convertible senior notes to institutional buyers, using part of the proceeds to buy back its 2027 and 2028 converts.
HALO
Market-moving news on Halozyme Therapeutics (NASDAQ: HALO): filings, earnings, deals and other events, from REDFILED.